Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WSR
2226
DELISTED
Whitestone REIT
WSR
| $2.6M | ﹤0.01% |
212,210
+70
| +0% | +$949 |
|
2227
First Community Bankshares
FCBC
$900M
| $2.6M | ﹤0.01% |
82,527
-1,097
| -1% | -$36.6K |
|
2228
Boot Barn
BOOT
$4.51B
| $2.59M | ﹤0.01% |
152,272
-151
| -0.1% | -$3.47K |
|
2229
Precigen
PGEN
$2.24B
| $2.59M | ﹤0.01% |
395,365
-332
| -0.1% | -$3.72K |
|
|
SUP
2230
DELISTED
Superior Industries International
SUP
| $2.58M | ﹤0.01% |
537,355
+145,626
| +37% | +$1.36M |
|
|
GTHX
2231
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.58M | ﹤0.01% |
134,960
+12,042
| +10% | +$451K |
|
2232
Northern Oil and Gas
NOG
$2.3B
| $2.58M | ﹤0.01% |
113,916
+7,333
| +7% | +$216K |
|
|
AKRX
2233
DELISTED
Akorn Inc
AKRX
| $2.57M | ﹤0.01% |
758,461
+114,275
| +18% | +$680K |
|
2234
PetMed Express
PETS
$41.7M
| $2.56M | ﹤0.01% |
110,126
-1,404
| -1% | -$37.5K |
|
|
LORL
2235
DELISTED
Loral Space and Communications, Inc.
LORL
| $2.56M | ﹤0.01% |
68,740
-132
| -0.2% | -$5.67K |
|
|
TGH
2236
DELISTED
Textainer Group Holdings limited
TGH
| $2.55M | ﹤0.01% |
256,185
+24,994
| +11% | +$278K |
|
2237
Century Communities
CCS
$1.91B
| $2.55M | ﹤0.01% |
147,672
-1,587
| -1% | -$33.1K |
|
|
CBAY
2238
DELISTED
Cymabay Therapeutics
CBAY
| $2.55M | ﹤0.01% |
323,599
-2,052
| -0.6% | -$19.5K |
|
|
APLS
2239
DELISTED
Apellis Pharmaceuticals
APLS
| $2.54M | ﹤0.01% |
192,439
-120
| -0.1% | -$1.84K |
|
2240
Karyopharm Therapeutics
KPTI
$43.5M
| $2.52M | ﹤0.01% |
17,923
-210
| -1% | -$35.4K |
|
2241
Option Care Health
OPCH
$3.45B
| $2.52M | ﹤0.01% |
176,388
+5,389
| +3% | +$71.1K |
|
|
CTRL
2242
DELISTED
Control4 Corporation
CTRL
| $2.52M | ﹤0.01% |
143,023
-88
| -0.1% | -$2.08K |
|
|
HNGR
2243
DELISTED
Hanger Inc.
HNGR
| $2.51M | ﹤0.01% |
+132,565
| New | +$2.56M |
|
2244
Forrester Research
FORR
$223M
| $2.51M | ﹤0.01% |
56,174
+1,730
| +3% | +$73.8K |
|
|
AKCA
2245
DELISTED
Akcea Therapeutics Inc
AKCA
| $2.51M | ﹤0.01% |
83,287
+10,634
| +15% | +$298K |
|
|
MOMO
2246
Hello Group
MOMO
$885M
| $2.51M | ﹤0.01% |
105,574
-2,702
| -2% | -$85K |
|
|
TSC
2247
DELISTED
TriState Capital Holdings, Inc.
TSC
| $2.51M | ﹤0.01% |
128,807
-93
| -0.1% | -$2.26K |
|
2248
GrafTech
EAF
$175M
| $2.5M | ﹤0.01% |
21,883
+943
| +5% | +$144K |
|
|
RFP
2249
DELISTED
Resolute Forest Products Inc.
RFP
| $2.5M | ﹤0.01% |
314,539
-6,356
| -2% | -$70.1K |
|
|
GNBC
2250
DELISTED
Green Bancorp, Inc
GNBC
| $2.49M | ﹤0.01% |
145,121
-1,012
| -0.7% | -$19.6K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.